SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
about
Chronic neutrophilic leukemia 2014: Update on diagnosis, molecular genetics, and managementEvaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literatureA novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case.Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.Clinical and genetic predictors of prognosis in myelodysplastic syndromes.Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical ApproachSurvival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.PRPF8 defects cause missplicing in myeloid malignancies.Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the disease.Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia.Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemiaSubclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemiaSomatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndrome.Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.Overlapping SETBP1 gain-of-function mutations in Schinzel-Giedion syndrome and hematologic malignancies.Clonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.Somatic SETBP1 mutations in myeloid malignanciesThe new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentAntagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.Molecular pathogenesis of myelodysplastic syndromes.Recent advances in understanding the molecular pathogenesis of myelodysplastic syndromes.Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Integrating genetics and epigenetics in myelodysplastic syndromes: advances in pathogenesis and disease evolution.-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.I walk the line: how to tell MDS from other bone marrow failure conditions.Chronic myelomonocytic leukemia prognostic classification and management: evidence base and current practice.Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable.The molecular pathogenesis of the myelodysplastic syndromes.Next-generation sequencing-based panel testing for myeloid neoplasms.Chronic neutrophilic leukemia 2016: Update on diagnosis, molecular genetics, prognosis, and management.CMML: Clinical and molecular aspects.Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.Genomics of chronic neutrophilic leukemia.Somatic SETBP1 mutations in myeloid neoplasms.Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.Mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia: a report from the Italian AIEOP study group.SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.A new player SETs in myeloid malignancy.SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms.
P2860
Q27009366-E7E23F47-EF35-40B7-95E9-0FFF4BA307DBQ28083489-DD15F5B1-AE5E-4421-85E1-DBEA20C72DD1Q30152631-41FDF08F-A4F3-4700-9674-EB17483D9C91Q33591367-CC1802C3-2E1F-4F35-A3D0-4B08ACB1FA1AQ33695906-537CEFF4-A2BB-4166-953A-49DA830F56BAQ33888064-52EC0934-3DC7-4319-97CA-B33BE9DDB291Q34037065-698D7B2E-3D0E-4C88-B5D0-8C9DC60883CDQ34429362-C84157EE-A803-483B-8E29-D61EA0F7F62DQ34667249-55C91BDC-EF26-45FD-B2B8-54616EDED14BQ34700714-D5F390B3-2BCA-43BF-AC60-8BB4A1E8BFDDQ34749589-97411B2B-859D-4CE0-B192-F3379B4EBA06Q34974064-828E09DC-9A33-4A2A-ABFF-F5CEF87B4606Q35252614-EF436282-043F-4942-9522-2F731B90F037Q36270003-C7769537-601B-4D30-A8C8-EDA330A769FBQ36323864-2BD2086D-9166-4C84-A32C-EE8FD4647DFFQ36693223-FA203F05-288D-4FA2-B108-A82A4BE6B58DQ36708989-7004E1C7-2E91-4FDA-B123-DDBA79D03F26Q37060418-6EFB5710-720F-48C1-B723-6653F6D7107CQ37151676-FAF33567-35FC-4AD3-9752-ECDF39B61D1BQ37707099-280B2F78-B3E9-49DA-938C-CBB4EC6B5CA2Q37724602-6F00725C-CC5A-40D4-B7A5-25BC8B9A3453Q38122703-BD248E49-EC49-41A7-BAA9-A86869E40065Q38130476-4C0EA6E3-C525-4057-AB4A-DBB1346C7B5AQ38218055-2DC7DCCB-E361-403A-B1F0-6896543E4ED6Q38226741-D3242952-B77F-4051-8A1C-4458FE25451FQ38235622-94CF8AE7-EDE7-44D2-91A9-FB9AB56891B9Q38241774-13DF4AA3-D03C-407C-B248-DEA769224F68Q38248429-2D1D4264-E991-443C-A411-204F00B3712FQ38341998-7F0272F0-5E28-455C-A339-1FAFDC8D80E3Q38453790-C49B9648-5BD9-4401-85EC-FC6F2AB405DAQ38678287-832C0E55-B687-499E-AE02-B9FA3C9B23E7Q38689508-3703DC7B-5CFE-44B4-9933-1CA30B329C14Q38835771-B09F3232-B04C-4064-B740-D848F5CFA990Q39059515-FC6CD2C2-0AD5-4738-AE12-9E5CCF4A12A4Q39266051-8F543C24-43A4-4AFB-8D3D-3B6030744CAEQ41183059-1CEA4EBD-BA10-434F-8780-DCE464CF11ABQ41259945-68303499-3A9E-4915-A60C-E8E7E35564A2Q42937128-F4B002DA-5528-455F-8C68-6E5E3054A1EBQ43123410-71DF4E9C-DAF3-4C3C-AA7F-D6C31771A7BBQ43135315-6375AD1C-7CC1-44A5-B76E-ACD5060AA7D0
P2860
SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@en
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@nl
type
label
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@en
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@nl
prefLabel
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@en
SETBP1 mutations in 658 patien ...... ndary acute myeloid leukemias.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
SETBP1 mutations in 658 patien ...... ondary acute myeloid leukemias
@en
P2093
A Renneville
E Delabesse
S de Botton
V Chesnais
V Gelsi-Boyer
P2860
P2888
P304
P356
10.1038/LEU.2013.35
P50
P577
2013-02-05T00:00:00Z